Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
SPARC can give good returns: Aashish Tater
4.45 pm | 17 May 2013 | Source: CNBC-TV18
Aashish Tater, Head of Research, Fortunewizard.com feels that there is lot of money that can be made in Sun Pharma Advance Research Company....
Hold Dr Reddys Laboratories: Prakash Diwan
6.10 pm | 14 May 2013 | Source: CNBC-TV18
One can hold Dr Reddys Laboratories, says Prakash Diwan, Chief Portfolio Strategist of Prakash Diwan's Wealth Circle, ECR.
Dr Reddy's Q4 cons net jumps 67% to Rs 571 cr
3.13 pm | 14 May 2013 | Source: Moneycontrol.com
Hyderabad-based Dr Reddy's fourth quarter consolidated net profit increased 67 percent year-on-year to Rs 571 crore, helped by surge in other income a...
Dr Reddys Labs trades firm ahead of Q4 earnings
11.07 am | 14 May 2013 | Source: Moneycontrol.com
Dr Reddys Laboratories was buzzing in trade ahead of its quarterly earnings announcement today. The company could see a boost this quarter in the bott...
Buy Dr Reddys Labs 2000 Call: VK Sharma
4.38 pm | 09 May 2013 | Source: CNBC-TV18
VK Sharma of HDFC Securities said one could consider buying Dr Reddys Labs 2000 Call, with a stop loss of Rs 40....
Dr Reddys Laboratories hits 52-week high, soars 5%
2.37 pm | 25 Apr 2013 | Source: Moneycontrol.com
Healthcare firm Dr Reddys Laboratories was the top gainer on benchmark indices, rising five percent to touch a new 52-week high of Rs 1,999.40 on Thur...
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.